@article{1432166,
      recid = {1432166},
      author = {Trabulsi, Edouard J. and Lallas, Costas D. and  Lizardi-Calvaresi, Anne E.},
      title = {Chemotherapy and immunotherapy in urologic oncology : a  guide for the advanced practice provider /},
      pages = {1 online resource},
      note = {Metastatic Neuroendocrine Carcinoma.},
      abstract = {This book is designed to familiarize clinical  practitioners in systemic therapy options and medical  management of urologic malignancies including prostate  cancer, bladder and upper tract urothelial carcinoma, and  renal cell carcinoma. Organized by organ system, the text  highlights new therapies such as novel forms of androgen  deprivation, cytotoxic chemotherapy, immune check point and  immunomodulatory agents, and targeted therapies. Written by  experts in the field, the book also reviews current  chemotherapy and immunotherapy regimens for genitourinary  malignancies and discusses indications, outcomes, and  toxicities, as well as clinical trial concepts. Each of the  book's chapters offers a bulleted box of clinical pearls on  the particular role of the APP. Chemotherapy and  Immunotherapy in Urologic Oncology: A Guide for the  Advanced Practice Provider is a resource for urologists,  uro-radiologists, medical clinicians and family  practitioners alike, familiarizing its audiences with  systemic therapy regimens for urologic malignancies, as  well as their expected outcomes and side effects.},
      url = {http://library.usi.edu/record/1432166},
      doi = {https://doi.org/10.1007/978-3-030-52021-2},
}